MedPath

Prevention of Recurrent Caries With Lactobacilli PRECAL

Not Applicable
Suspended
Conditions
Dental Caries in Children
Interventions
Other: Placebo
Other: Probiotic bacteria
Registration Number
NCT04929340
Lead Sponsor
Umeå University
Brief Summary

The aim of this study was to compare the effect of drops containing probiotic bacteria (Lactobacillus reuteri 17938, Lactobacillus reuteri PTA 5289, Biogaia AB, Sweden) on the incidence of dental caries with placebo drops in preschool children undergoing comprehensive restorative treatment under general anesthesia or conscious sedation. The project will be conducted at three specialist centers (Umeå University, Umeå, Sweden, Maxillo-facial unit, Halmstad Hospital, Sweden; Eastman Institute, Stockholm, Sweden) and employ a randomized placebo-controlled design with two parallel arms. The study will be performed double-blind and neither the parents nor the clinicians will be aware of the content of the drops. The follow-up period is one year.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Preschool children, 2-5 year of age
  • with Early childhood caries (ECC) or
  • severe Early childhood caries (S-ECC)
  • scheduled for restorations and extractions under general anesthesia or any form of sedation
  • The obligate requirement is that the child should be fully treated and managed with aspect to caries within a period of not more than two months.
Exclusion Criteria
  • medically comprised children
  • children with severe cognitive problems or dysfunctional families
  • families planning to relocate within the next year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboPlacebo5 drops each day before bedtime but after toothbrushing. The placebo drops had identical composition color and taste but no probiotic bacteria.
experimentalProbiotic bacteria5 drops each day before bedtime but after toothbrushing. L. reuteri DSM 17938, L. reuteri ATCC PTA 5289, with a minimum of 100 million live bacteria of each strain.
Primary Outcome Measures
NameTimeMethod
dental caries12 months

dental caries (International Caries Detection and Assesment System, ICDAS level)

Secondary Outcome Measures
NameTimeMethod
visible supra-gingival plaque12 months

presence of visible supragingival plaque on buccal surfaces upper anterior teeth (yes/no)

Trial Locations

Locations (3)

Eastmaninstitutet Pedodonti, Stockholm

🇸🇪

Stockholm, Sweden

Barntandvården Halmstad

🇸🇪

Halmstad, Sweden

Tandläkarhögskolan Umeå

🇸🇪

Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath